Measurement of circulating cell-derived microparticles by flow cytometry: sources of variability within the assay

Lisa Ayers1, Malcolm Kohler, Paul Harrison

  • 1Department of Clinical Immunology, Churchill Hospital, Oxford, UK. lisa.ayers@nhs.net

Thrombosis Research
|January 25, 2011
PubMed
Abstract

Insights

Standardizing the measurement of circulating cell-derived microparticles (MPs) is crucial for understanding their role in disease. This study identified key pre-analytical variables that significantly impact MP quantification, highlighting the need for consistent protocols.

Area of Science:

  • Biomedical research
  • Flow cytometry
  • Clinical diagnostics

Background:

  • Circulating cell-derived microparticles (MPs) are implicated in various diseases.
  • Elevated MP levels are observed in numerous pathological conditions.
  • Accurate measurement of MPs is essential but hindered by a lack of standardization.

Purpose of the Study:

  • Establish a reliable flow cytometric assay for measuring distinct MP subtypes.
  • Identify critical variables affecting MP quantification.
  • Improve standardization in MP measurement for disease research.

Main Methods:

  • Phenotypic identification of circulating MPs (platelet, endothelial, leukocyte, annexin-V positive).
  • Investigated effects of time from venepuncture to centrifugation.
  • Assessed impact of washing steps, centrifugation number, freezing, and thawing on MP levels.

Main Results:

  • Increased time to centrifugation elevated MP levels.
  • Washing and double centrifugation decreased annexin-V positive (AnnV+) and platelet-derived MPs (PMPs).
  • Freeze-thaw cycles increased AnnV+ and PMPs, while long-term storage decreased MP levels.

Conclusions:

  • Minor protocol variations significantly impact MP quantification.
  • This study is among the first to standardize circulating MP measurement.
  • Standardization is vital for MP technology development and comparative research in disease states.